TITLE

11. The 2012 SEMDSA Treatment Algorithm for Type 2 Diabetes

PUB. DATE
June 2012
SOURCE
Journal of Endocrinology, Metabolism & Diabetes of South Africa;Jun2012, Vol. 17 Issue 2, pS36
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article discusses the development of the 2012 treatment algorithm for type 2 diabetes by the Society for Endocrinology, Metabolism and Diabetes of South Africa (SEMDSA). It explores challenges faced by the committee in formulating the guideline for the pharmacological management of type 2 diabetes, and explores several considerations when using the algorithm. A chart providing data on various antihyperglycaemic agents used in the management of diabetes is also presented.
ACCESSION #
78950849

 

Related Articles

  • Adherence to the Standard Guidelines for Prescription of Antidiabetic Agents in Patients with Type 2 DM. Alhadidi, Qasim M.; Sahib, Ahmed S.; Jaffer, Ali M.; Ismael, Maha H.; Hassan, Ekhlas K.; Shareef, Saja M.; Shoesh, Asmaa M.; Dawood, Asia S. // Journal of Applied Pharmaceutical Science;Jul2012, Vol. 2 Issue 7, p1 

    Prescription of appropriate antihyperglycemic agent depending on the standard guidelines has an important role in controlling diabetes and improving patient health. The aim of the present prospective study is to follow-up the adherence of prescribers to the standard guidelines for the...

  • No Need for the Needle (at First). Davidson, Mayer B. // Diabetes Care;Oct2008, Vol. 31 Issue 10, p2070 

    The author comments on a study by Chen et al. which describes an approach to the initial treatment of newly diagnosed type 2 diabetic patients with severe hyperglycemia entailing intensive insulin therapy during 10 to 14 days of hospitalization. According to the author, one should carefully...

  • Patient Preferences for Noninsulin Diabetes Medications: A Systematic Review. Purnell, Tanjala S.; Joy, Susan; Little, Emily; Bridges, John F. P.; Maruthur, Nisa // Diabetes Care;Jul2014, Vol. 37 Issue 7, p2055 

    OBJECTIVE An evidence-based synthesis of patient preferences for management of hyperglycemia is needed. Our objective was to systematically review patient preferences for noninsulin diabetes medications in adults with type 2 diabetes. RESEARCH DESIGN AND METHODS We searched the PubMed, Embase,...

  • Стратегии лечения сахарного диабета 2 типа: почему мы не видим «слона в посудной лавке»? Levit, S.; Giveon, S.; Филиппов, Ю. И.; Domuschiev, I. Panchev; Zivony, A. // Diabetes Mellitus (20720351);2016, Vol. 19 Issue 4, p341 

    During the past two decades, the unequivocally recommended treatment method of Type 2 diabetes mellitus was insulin administration and intensification in the earliest possible stage of the diagnosis. This approach is not only unfounded but was never scientifically proven. Yet, it has been...

  • Antihyperglycaemics: prescribing rate unchanged by rosiglitazone warning.  // Reactions Weekly;12/12/2009, Issue 1282, p5 

    The article discusses research being done on overall utilisation of antihyperglycaemics in the U.S. Military Health System. It references the study "Temporal Trends in Anti-Diabetes Drug Use in Tricare Following Safety Warnings in 2007 About Rosiglitazone," by K. A. Stewart, published in the...

  • UPDATE ON TREATMENT OF TYPE 2 DIABETES MELLITUS. RUNGBY, JORGEN // Problemy Endokrinologii;2017 Supplement, p6 

    Type 2 diabetes is a heterogeneous disease and therefore it may be complicated to treat hyperglycaemia. Treatment is ideally based on pathophysiological knowledge about the causes of hyperglycaemia in the individual patient: «The right pill in the right mouth». The lecture will focus on...

  • Type 2 Diabetes: Updated Evidence Requires Updated Decision Making. SHAUGHNESSY, ALLEN F.; ERLICH, DEBORAH R.; SLAWSON, DAVID C. // American Family Physician;7/1/2015, Vol. 92 Issue 1, p22 

    The article comments on the paper "Management of blood glucose with noninsulin therapies in type 2 diabetes" by C. M. George and colleagues. Topics discussed include the small subset of patients who benefit from normalizing blood glucose levels, the tendency to over-treat hyperglycemia using...

  • How Doctors Choose Medications to Treat Type 2 Diabetes. Grant, Richard W.; Wexler, Deborah J.; Watson, Alice J.; Lester, William T.; Cagliero, Enrico; Campbell, Eric G.; Nathan, David M. // Diabetes Care;Jun2007, Vol. 30 Issue 6, p1448 

    OBJECTIVE -- Glycemic control remains suboptimal despite the wide range of available medications. More effective medication prescription might result in better control. However, the process by which physicians, choose glucose-lowering medicines is poorly understood. We sought to study the means...

  • Updated guidelines for type 2 diabetes. Elliott, William T. // Neurology Alert;Dec2008 Pharmacology, p2 

    The article reports on the move by the American Diabetes Association and the European Association for the Study of Diabetes to update their treatment guidelines and algorithms for the treatment of type 2 diabetes. The updates are said to reflect safety issues about the thiazolidinediones (TZDs)...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics